BioCentury
ARTICLE | Company News

NewLink, Merck, U.S. Department of Health and Human Services infectious news

January 19, 2015 8:00 AM UTC

HHS’s Biomedical Advanced Research and Development Authority (BARDA) awarded NewLink’s BioProtection Systems subsidiary a $30 million contract to manufacture and develop Ebola vaccine rVSV-EBOV throu...